Docoh
Loading...

TEVA Teva- Pharmaceutical Industries

Teva Pharmaceutical Industries Ltd. engages in the development and production of medicines. Its products include medicines for cardiovascular diseases, pain relievers, obesity, cancer and supportive care, infectious diseases and human immunodeficiency viruses, and colds and coughs. The company was founded in 1901 and is headquartered in Petah Tikva, Israel.

Company profile

Ticker
TEVA, TEVJF
Exchange
CEO
Kaare Schultz
Employees
Incorporated
Location
Fiscal year end
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
SEC CIK

TEVA stock data

(
)

Calendar

28 Jul 21
4 Aug 21
31 Dec 21
Quarter (USD)
Jun 21 Mar 21 Dec 20 Sep 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 2.44B 2.44B 2.44B 2.44B 2.44B 2.44B
Cash burn (monthly) (positive/no burn) (positive/no burn) (positive/no burn) 243.33M (positive/no burn) (positive/no burn)
Cash used (since last report) n/a n/a n/a 284.85M n/a n/a
Cash remaining n/a n/a n/a 2.15B n/a n/a
Runway (months of cash) n/a n/a n/a 8.8 n/a n/a

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
14 Jun 21 Barer Sol J Restricted Share Units Ordinary Shares Grant Aquire A No No 0 25,791 0 25,791
14 Jun 21 Crane Rosemary A Restricted Share Units Ordinary Shares Grant Aquire A No No 0 14,479 0 14,479
14 Jun 21 Elstein Amir Restricted Share Units Ordinary Shares Grant Aquire A No No 0 14,479 0 14,479
14 Jun 21 Halfon Jean Michel Restricted Share Units Ordinary Shares Grant Aquire A No No 0 14,479 0 14,479
14 Jun 21 Abbas Hussain Restricted Share Units Ordinary Shares Grant Aquire A No No 0 14,479 0 14,479

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

13F holders
Current Prev Q Change
Total holders 0 2 EXIT
Opened positions 0 2 EXIT
Closed positions 2 0 NEW
Increased positions 0 0
Reduced positions 0 0
13F shares
Current Prev Q Change
Total value 0 1.26B EXIT
Total shares 0 130.45M EXIT
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
Largest transactions
Shares Bought/sold Change
Capital Research Global Investors 0 -130.14M EXIT
Wellington Management 0 -310.79K EXIT

Financial report summary

?
Management Discussion
  • The discussion that follows includes a comparison of our results of operations and liquidity and capital resources for fiscal years 2020 and 2019. For a comparison of our results of operations and financial condition for fiscal years 2019 and 2018, see “Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our 2019 Annual Report on Form10-K,
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
8th grade Avg
New words: AMCo, Ameri, arguing, arisi, aser, assigned, Aurobindo, buying, ca, comp, Delhi, dis, drawn, driven, enrichment, eventual, FASB, fraud, fraudulent, fremanezumab, Green, Index, interference, Irvine, Lanham, libel, missed, monopolization, Mylan, NaNaccount, National, ng, opportunity, pace, paused, plausibly, proactively, promulgated, PTAB, Racketeer, reassessment, refractory, rehensive, satisfactorily, scheme, thr, Travere, Tribunal, unfair, unjust, Washington, Waymade
Removed: acetate, bortezomib, combining, competing, Draft, glatiramer, memantine, Supplementary